Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068366 · ClinicalTrials.gov registry record
Nickel Allergy With Septal Closure Devices
A clinical trial, sponsored by University of Utah.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01068366: Clinical Trial study, sponsored by University of Utah.
NCT01068366 is a clinical trial that was terminated before completion, run by University of Utah. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01068366 was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study is for patients who have been diagnosed with either a Patent Foramen Ovale \[PFO\] or an Atrial Septal Defect \[ASD\]. These are a type of hole located in the wall that separates the top two (2) chambers of the heart. You have been recommended to receive an atrial septal occluder device \[a device specifically designed to close PFOs and ASDs\] implanted in your heart to close this hole. Because these devices are made of materials that contain nickel, this trial is being conducted to perform blood nickel tests on those patients already referred for an atrial septal occluder device such as yourself. The purpose of this study is to compare levels of nickel in the blood in patients receiving either the Amplatzer or the Helex devices.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-11 |
Why NCT01068366 stopped before completion
NCT01068366 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01068366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01068366 about?
NCT01068366 is a clinical study titled "Nickel Allergy With Septal Closure Devices". This study is for patients who have been diagnosed with either a Patent Foramen Ovale \[PFO\] or an Atrial Septal Defect \[ASD\]. These are a type of hole located in the wall that separates the top two (2) chambers of the heart. You have been recommended to receive an atrial septal occluder device \...
What is the current status of trial NCT01068366?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2010-02. Estimated completion is 2010-11.
Who is sponsoring clinical trial NCT01068366?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia